Trustee, Scientific Advisor
Buchanan Professor of Genetics,
University of Edinburgh
Adrian P. Bird, Ph.D. has been a trustee of RSRT since the inception of the organization. He is the world’s leading expert in the gene MECP2, which causes Rett Syndrome when mutated. His lab discovered the MeCP2 protein in the early 1990′s and currently studies the structure and function of the mammalian genome and in particular the role of DNA methylation, a fundamental mechanism controlling gene expression.
In February of 2007 Prof. Bird published the landmark paper in Science establishing the principle of reversibility of Rett symptoms in mice, providing the proof-of principle which suggests reversal may be possible in humans.
Prof. Bird became Buchanan Professor of Genetics at the University of Edinburgh in 1990. There he played a prominent role in setting up the Wellcome Trust Centre for Cell Biology, where he was Director from 1999 to 2011. Dr. Bird was a Governor of the Wellcome Trust, the world’s largest medical research charity, from 2000 to 2010. In April of 2007 he was appointed Deputy Chairman and for three years oversaw assets totaling more than $27 billion.
Prof. Bird is also a trustee of Cancer Research UK and the Kirkhouse Trust. He serves on the editorial boards of Molecular and Cellular Biology and Molecular Cell. He is past Chairman of the Scientific Advisory Board for the Rett Syndrome Research Foundation, co-founded by RSRT Executive Director Monica Coenraads in 1999.
Prof. Bird studied at the University of Sussex and the University of Edinburgh. He has received numerous awards and honors, including the prestigious Howard Hughes International Fellowship, the Louis-Jeantet Prize for Medicine and the Gabor Medal of the Royal Society. He is a Fellow of the Royal Societies of London and Edinburgh and of the Academy of Medical Sciences.
In March 2011 Prof. Bird was awarded a Gairdner Foundation prize, one of the most prestigious medical honors in the world, for his discoveries in the field of DNA methylation and its role in gene expression. In 2014 he received the BBVA Foundation Frontiers of Knowledge Prize in Biomedicine.
In 2014 Professor Bird received a Knighthood for his services to science.